FI962324A - N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF - Google Patents
N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF Download PDFInfo
- Publication number
- FI962324A FI962324A FI962324A FI962324A FI962324A FI 962324 A FI962324 A FI 962324A FI 962324 A FI962324 A FI 962324A FI 962324 A FI962324 A FI 962324A FI 962324 A FI962324 A FI 962324A
- Authority
- FI
- Finland
- Prior art keywords
- neuroleptics
- asf
- pct
- azabicycloalkane derivatives
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Ink Jet (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4341403A DE4341403A1 (de) | 1993-12-04 | 1993-12-04 | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
PCT/EP1994/003913 WO1995015327A1 (en) | 1993-12-04 | 1994-11-26 | N-substituted azabicycloalkane derivatives as neuroleptika asf |
Publications (3)
Publication Number | Publication Date |
---|---|
FI962324A0 FI962324A0 (fi) | 1996-06-03 |
FI962324A true FI962324A (fi) | 1996-06-03 |
FI113644B FI113644B (fi) | 2004-05-31 |
Family
ID=6504205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI962324A FI113644B (fi) | 1993-12-04 | 1996-06-03 | Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi |
Country Status (13)
Country | Link |
---|---|
US (1) | US5703091A (fi) |
EP (1) | EP0731802B1 (fi) |
JP (1) | JP3935201B2 (fi) |
AT (1) | ATE194620T1 (fi) |
AU (1) | AU680583B2 (fi) |
BR (1) | BR9408246A (fi) |
DE (2) | DE4341403A1 (fi) |
ES (1) | ES2148476T3 (fi) |
FI (1) | FI113644B (fi) |
IL (1) | IL111861A (fi) |
NO (1) | NO306346B1 (fi) |
TW (1) | TW285667B (fi) |
WO (1) | WO1995015327A1 (fi) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19848521A1 (de) * | 1998-10-21 | 2000-04-27 | Basf Ag | Verfahren zur Herstellung von (+)-exo-6-Phenyl-3-azabicyclo-[3.2.0]heptanen |
DE19854147A1 (de) * | 1998-11-24 | 2000-05-25 | Basf Ag | Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht |
TWI244481B (en) | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US6586446B1 (en) | 1999-10-15 | 2003-07-01 | Bristol-Myers Squibb Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
US6784200B2 (en) | 2000-10-13 | 2004-08-31 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
GB0015562D0 (en) * | 2000-06-23 | 2000-08-16 | Pfizer Ltd | Heterocycles |
SE0100326D0 (sv) | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
CA2440803A1 (en) * | 2001-03-07 | 2002-09-12 | Pfizer Products Inc. | Modulators of chemokine receptor activity |
MXPA05001726A (es) * | 2002-08-14 | 2005-05-27 | Abbott Lab | Compuestos azabiciclicos son agentes activos del sistema nervioso central. |
ATE423769T1 (de) * | 2002-08-23 | 2009-03-15 | Ranbaxy Lab Ltd | Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten |
DE60227576D1 (de) * | 2002-12-10 | 2008-08-21 | Ranbaxy Lab Ltd | 3,6-DISUBSTITUIERTE AZABICYCLO i3.1.0 -HEXANDERIVATIVE ALS ANTAGONISTEN DES MUSCARINREZEPTORS |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE602005004144T2 (de) | 2004-06-09 | 2009-01-29 | F. Hoffmann-La Roche Ag | Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mittel |
GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
US7665658B2 (en) | 2005-06-07 | 2010-02-23 | First Data Corporation | Dynamic aggregation of payment transactions |
EP2029536B1 (en) | 2006-04-28 | 2013-08-28 | Laboratorios Del. Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP1849771A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP1849772A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
GB0625198D0 (en) * | 2006-12-18 | 2007-01-24 | Glaxo Group Ltd | Chemical compounds |
GB0809479D0 (en) * | 2008-05-23 | 2008-07-02 | Glaxo Group Ltd | Novel compounds |
EP2595989B1 (en) | 2010-05-06 | 2016-07-13 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
EP2621902B1 (en) | 2010-09-28 | 2017-04-12 | Panacea Biotec Ltd | 3-azabicyclo[3.1.0]hexane compounds useful for the treatment of cns disorders |
EP2642998B1 (en) | 2010-11-24 | 2020-09-16 | The Trustees of Columbia University in the City of New York | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
JP6021824B2 (ja) | 2011-02-02 | 2016-11-09 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | イオンチャネルのモジュレーターとしてのピロロピラジン−スピロ環式ピペリジンアミド |
MX2013009393A (es) | 2011-02-18 | 2013-08-29 | Vertex Pharma | Piperidinamidas cromano-espirociclicas como moduladores de canales de iones. |
US8828996B2 (en) | 2011-03-14 | 2014-09-09 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
US9333202B2 (en) | 2012-05-01 | 2016-05-10 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease |
WO2014151959A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
US9637450B2 (en) | 2013-03-14 | 2017-05-02 | The Trustees Of Columbia University In The City Of New York | Octahydrocyclopentapyrroles, their preparation and use |
EP3495357B1 (en) | 2013-03-14 | 2021-05-05 | The Trustees of Columbia University in the City of New York | 4-phenylpiperidines, their preparation and use |
WO2014151936A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles, their preparation and use |
ES2707739T3 (es) | 2013-09-26 | 2019-04-04 | Cadent Therapeutics Inc | Moduladores negativos de octahidro-ciclopenta[c]pirrol selectivo de NR2B |
MX2016014197A (es) | 2014-04-30 | 2017-05-03 | Univ Columbia | 4-fenilpiperidinas sustituidas, su preparacion y uso. |
JO3579B1 (ar) * | 2014-09-26 | 2020-07-05 | Luc Therapeutics Inc | مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول |
WO2017021920A1 (en) * | 2015-08-05 | 2017-02-09 | Indivior Uk Limited | Dopamine d3 receptor antagonists having a bicyclo moiety |
WO2018021447A1 (ja) | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
KR20200112910A (ko) | 2018-01-26 | 2020-10-05 | 시오노기 앤드 컴파니, 리미티드 | 도파민 d3 수용체 길항 작용을 갖는 축환 화합물 |
US10604489B2 (en) | 2018-02-05 | 2020-03-31 | Alkermes, Inc. | Compounds for the treatment of pain |
JOP20210110A1 (ar) | 2018-11-14 | 2023-01-30 | Janssen Pharmaceutica Nv | تحسين الأساليب الاصطناعية لإعداد مركبات حلقية متغايرة منصهرة كمُعدِّلات مستقبلات الأوريكسين |
US11274082B2 (en) | 2019-05-31 | 2022-03-15 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
EP3976192A1 (en) | 2019-05-31 | 2022-04-06 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
CN114957087A (zh) * | 2022-04-13 | 2022-08-30 | 湖南复瑞生物医药技术有限责任公司 | 一种帕罗韦德中间体制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL110185C (fi) * | 1958-04-22 | |||
NO154582C (no) * | 1978-10-20 | 1986-11-05 | Ferrosan Ab | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
DE3571436D1 (en) * | 1984-12-21 | 1989-08-17 | Duphar Int Res | New pharmaceutical compositions having anti-psychotic properties |
US5055470A (en) * | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
US4994460A (en) * | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
DE4112353A1 (de) * | 1991-04-16 | 1992-10-22 | Basf Ag | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung |
US5216018A (en) * | 1992-02-14 | 1993-06-01 | Du Pont Merck Pharmaceutical Company | Hydroisoindolines and hydroisoquinolines as psychotropic |
US5532243A (en) * | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
DE4243287A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE4219973A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
-
1993
- 1993-12-04 DE DE4341403A patent/DE4341403A1/de not_active Withdrawn
-
1994
- 1994-11-26 BR BR9408246A patent/BR9408246A/pt not_active Application Discontinuation
- 1994-11-26 US US08/656,240 patent/US5703091A/en not_active Expired - Lifetime
- 1994-11-26 WO PCT/EP1994/003913 patent/WO1995015327A1/en active IP Right Grant
- 1994-11-26 ES ES95903284T patent/ES2148476T3/es not_active Expired - Lifetime
- 1994-11-26 JP JP51538295A patent/JP3935201B2/ja not_active Expired - Fee Related
- 1994-11-26 AU AU12403/95A patent/AU680583B2/en not_active Ceased
- 1994-11-26 DE DE69425273T patent/DE69425273T2/de not_active Expired - Lifetime
- 1994-11-26 AT AT95903284T patent/ATE194620T1/de active
- 1994-11-26 EP EP95903284A patent/EP0731802B1/en not_active Expired - Lifetime
- 1994-12-02 IL IL11186194A patent/IL111861A/xx not_active IP Right Cessation
- 1994-12-05 TW TW083111264A patent/TW285667B/zh active
-
1996
- 1996-06-03 NO NO962286A patent/NO306346B1/no not_active IP Right Cessation
- 1996-06-03 FI FI962324A patent/FI113644B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1995015327A1 (en) | 1995-06-08 |
DE69425273D1 (de) | 2000-08-17 |
NO306346B1 (no) | 1999-10-25 |
IL111861A (en) | 1999-08-17 |
FI962324A0 (fi) | 1996-06-03 |
ATE194620T1 (de) | 2000-07-15 |
FI113644B (fi) | 2004-05-31 |
DE69425273T2 (de) | 2001-01-18 |
NO962286L (no) | 1996-06-03 |
AU680583B2 (en) | 1997-07-31 |
US5703091A (en) | 1997-12-30 |
TW285667B (fi) | 1996-09-11 |
EP0731802A1 (en) | 1996-09-18 |
NO962286D0 (no) | 1996-06-03 |
IL111861A0 (en) | 1995-03-15 |
DE4341403A1 (de) | 1995-06-08 |
BR9408246A (pt) | 1997-05-27 |
JP3935201B2 (ja) | 2007-06-20 |
ES2148476T3 (es) | 2000-10-16 |
JPH09506346A (ja) | 1997-06-24 |
AU1240395A (en) | 1995-06-19 |
EP0731802B1 (en) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI962324A (fi) | N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF | |
ATE172968T1 (de) | Substituierte azadioxacycloalkene und ihre verwendung als fungizide | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
IL110494A0 (en) | Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them | |
AU3563695A (en) | Novel piperidine derivatives with paf antagonist activity | |
ATE189458T1 (de) | Dipeptidische p-amidinobenzylamide mit n- terminalen sulfonyl- bzw. aminosulfonylresten | |
NO962285L (no) | N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika | |
ATE144497T1 (de) | N-substituierte 3-azabicyclo(3.2.0>heptan- derivate als neuroleptika | |
FI970449A (fi) | N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |